{"url_path":"/sec/pdsb/8-k/2026-08-11/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1472091/0001140361-26-032142-index.html","accession_number":"0001140361-26-032142","cik":"0001472091","ticker":"PDSB","issuer_name":"PDS Biotechnology Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1472091/0001140361-26-032142-index.html","primary_entity_key":"0001472091","primary_entity_name":"PDS Biotechnology Corp"},"word_count":138,"has_tables":true,"body_markdown":"Item 7.01\n\nRegulation FD Disclosure.\n\nOn August 11, 2026, PDS Biotechnology Corporation issued a letter to its shareholders which was posted on the Company’s Investor\nRelations website at pdsbiotech.com/index.php/investors. A copy of the letter to shareholders is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.\n\nThe information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished pursuant to Item\n7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into\nany registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}